|
Research Interests
I
am the Principle Investigator and Director of the MU
Center for Phytonutrient and Phytochemical Studies. The MU Center
for Phytonutrient and Phytochemical Studies is a comprehensive research
program that investigates the molecular mechanisms of phytochemicals
and phytonutrients in human disease. The Center fosters research to
determine the safety and efficacy of botanicals or plants in the treatment
of human disease. The Centers current research investigates molecular
mechanisms of the phytoestrogen, antioxidant, and polyphenol actions
in three human diseases: Cancer, Neurodegenerative disease and Immune-mediated
abnormalities. (Please refer to the Botanical Center web site at www.phyto-research.org
for more detailed information.)
My long-term
research interests involve the understanding of the mechanism of action
of the sex steroids and their receptors, in particular the estrogen
receptors. My lab's research goals use the estrogen receptor-alpha (ERa)-minus
mice to look for new estrogen response pathways (i.e. novel estrogen
receptors) and to find novel functional roles for the classic estrogen
receptor. This is a hot research area for me because of the increased
interest in environmental estrogens and our observations that some of
these environmental estrogens are inducing responses in the ERa-minus
mice. These estrogen-induced responses in an ERa-minus mouse are indicative
of the existence of an additional estrogen receptor. Other major interests
in my laboratory are: 1) The trinucleotide repeat genetic diseases,
primarily because many trinucleotide repeats with unknown function are
found in several of the steroid receptor genes; and, 2) The imprinting
signals of endocrine disrupters, such as the environmental estrogens,
especially those potentially acting via DNA-methylation signaling pathways.
The main
long-term goals of my research program are to find novel functions for
both estrogens and estrogen response proteins, and then to identify
the molecular mechanisms mediating these functions. To pursue these
goals, we "knocked out" the estrogen receptor-alpha (ERa) gene in mice
via homologous recombination and asked the following question: Would
an ERa-minus mouse respond to any known estrogen, estrogen metabolite
or exogenous (natural or synthetic) estrogen analog, if it lacked the
classic full length ERa protein? If ERa-minus mice did respond,
then we would know that at least one estrogen response protein other
than ER exists. The working hypothesis was that several non-ERa response
proteins exist and that in transgenic ERa-minus mice we would see a
response to estrogens, such as the catechol estrogens.
We have found
in ERa-minus mice a uterine lactoferrin mRNA response to 4-hydroxyestradiol,
methoxychlor and kepone, but not to estradiol. We now hypothesize
that: A) 4-hydroxyestradiol and these other biologically important estrogens
work through their own unique non-classical, estrogen response (NCER)
proteins; and B) NCER "receptors" can be readily characterized in the
ER-minus mouse background. Using this mouse model system we are characterizing
the 4-hydroxyestradiol and methoxychlor responses and the putative 4-hydroxyestradiol
and methoxychlor receptors. Specifically: Aim #1, Characterize
lactoferrin mRNA response to 4-hydroxyestradiol and methoxychlor in
ER-minus mice; Aim #2, Characterize the putative 4-hydroxyestradiol
and methoxychlor receptors in primary ER-minus uterine cell cultures;
Aim #3, Characterize potential responses to estradiol in ER-minus
mice; Aim #4, Characterize estrogen responses unique to 4-hydroxyestradiol
and methoxychlor; and Aim #5, Clone the putative 4-hydroxyestradiol
and methoxychlor receptors.
Our working
hypothesis is that estrogen responses in behavior, in bone, in glucose
homeostasis, and in the reproductive, immune, and cardiovascular systems
may not be mediated exclusively by the classical ERa or newly described
ERb proteins, but by additional non-classical estrogen response (NCER)
proteins. Studying specific mouse NCER proteins will lead to a better
understanding of estrogen's developmental, physiological, behavioral,
and biochemical roles in humans.
| Active
Support [top] |
|
|
DAMD 17-98-1-8529
(Dennis Lubahn, PI)
Army Prostate Cancer Program Idea
|
7/01/98-12/31/00
15% effort
$125,000 per year direct |
Do Soy
Isoflavones Provide Protection Against Prostate Cancer Via a Classical
Estrogen Receptor-alpha (ERa) Independent Mechanism?
|
1PO1-ES 10535
(Dennis Lubahn, PI and Center Director)
NIH-RFA Botanicals Center |
3/01/00-2/28/05
40% effort
$5,701,021 total |
MU Center
for Phytonutrient and Phytochemical Studies
|
Collaboration
w/ UI, MU & Purdue (Elizabeth Jeffery, PI University of IL)
USDA-IAFAS (Ruth MacDonald, local PI) |
10/30/2000
to 8/31/2004
.5% effort
$2,100,000 ($384,002 to MU) |
Component
interactions for efficacy of functional foods
|
PI
P20 CA86290-01 (Wynn Volkert, PI)
NIH, NCI
Center for Single Photo-Emitting Cancer Imaging Agents |
10/1/00-4/1/03
5% effort
$887,237 Total direct |
Sub-project:
Combinatorial Approach to Identification of Prostate Tumor Avid
Peptides for Cancer Radioimaging
|
(Ruth MacDonald,
PI) Project #FEFC0250
American Institute for Cancer Research |
2/1/01-12/31/02
3% effort
$165,000 |
Influence
of Phytoestrogens and Estrogens on Colon Cancer in Estrogen Receptor-alpha
and -beta Knockout Mice
|
| Older
Support [top] |
|
R01-ES08272
(Dennis Lubahn, PI)
RFA/NIEHS
|
07/01/96-06/30/99
10% effort
$100,000 direct costs per year |
Environmental
Estrogen Receptors in ER-minus Mice
The major goal is to characterize a non-ER protein, the putative
"methoxychlor receptor."
|
DAMD 17-96-1-6055
(Dennis Lubahn, PI)
Army Breast Cancer Program IDEA |
07/01/96-06/30/00
10% effort
$51,370 direct costs per year |
Estrogen
Effects on Breast Tumor Growth in Estrogen Receptor-Minus Mice
This pilot grant is to help elucidate the potential effects of
estrogen in human breast cancer, which are not mediated though
the classical estrogen receptor gene. An ER-minus, nude mouse
will be bred to examine estrogen's in vivo growth effects
on ER-minus breast tumor cell lines.
|
R825295 (Dennis
Lubahn, PI)
Grants for Research/EPA |
02/01/97-01/31/99
10% effort
$54,892 direct first year
$75,245 second |
Methoxychlor
and Environmental "Estrogen" Receptors in ER-minus Mice
Cloning of
the putative "methoxychlor receptor."
|
DAMD17-97-1-7171
(Dennis Lubahn, PI)
Army Breast Cancer Program IDEA |
09/1/97-8/30/00
20% effort
$68,493 direct costs per year |
Breast
Cancer Associated Estrogen Receptors: Catechol Estrogen Receptors
in ER-Minus Mice
Cloning and
characterization of the putative "catechol estrogen receptor."
|
R01 ES08293 (Fred
vom Saal, PI)
RFA/NIEHS |
07/01/96-06/30/00
5% effort
$100,000 direct costs per year |
Effects
of endocrine disrupters on offspring
The major goal is to study the effects of estrogenic environmental
pesticides in adult mammals after in utero exposure. We
will use the ER-minus mice to assess the effects of fetal exposure
to weak environmental estrogens.
|
| Army Prostate
Cancer grant (Dennis Lubahn, PI) |
7/01/98-12/31/00
15% effort
$125,000 per year
direct |
Utilizes TRAMP/ERaKO
mice to study effects of soy phytoestrogens on prostate cancer.
No studies on DNA methylation are included in this study and thus
it does not overlap except for providing tissues for the first
year of the proposed study. No funds are requested for these tissue
isolations during the first year.
|
Research
Awards and Fellowships [top]
1978-1980 National
Research Service Award
1985 Young
Investigator Award - Academy of Clinical Laboratory Physicians &
Scientists
1987 Mellon
Postdoctoral Fellowship
1988 National
Institutes of Health Postdoctoral Fellowship
1989-1992 Pew
Scholar in the Biomedical Sciences
1999 MU Provost Outstanding Junior Faculty Research and
Creativity Activity Award

|